About ATMPs, SOPs and GMP: The Hurdles to Produce Novel Skin Grafts for Clinical Use

The treatment of severe full-thickness skin defects represents a significant and common clinical problem worldwide. A bio-engineered autologous skin substitute would significantly reduce the problems observed with today's gold standard